1. Baldueva I.A., Semiglazov V.F., Pipia N.P., Nehaeva T.L., Danilova A.B., Avdonkina N.A., Novik A.V., Protsenko S.A., Semiglazova T.Yu., Karitsky A.P., Belyaev A.M. Development of a method of immunotherapy in breast cancer patients with exhausted capabilities standard treatment. Rossiyskiy bioterapevticheskiy zhurnal = Russian Journal of Biotherapy, 2018, Vol. 17 (S), pp. 5-6. (In Russ.)
2. Nehaeva T.L. Autologous dendritic cell vaccine optimization for therapy of patients with disseminated malignant neoplasms. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology, 2013, Vol. 3, no. 57, pp. 52-56. (In Russ.)
3. Novik A.V., Protsenko S.A., Anokhina Ye.М., Semyonova А.I., Nekhayeva T.L., Teletayeva G.М., Danilova A.B., Latipova, D.Kh. Pipia N.P., Avdonkina N.А., Zozulya А.Yu., Oganesyan A.P., Balduyeva I.A. Thirty years experience of melanoma therapy in N.N. Petrov National Medical Research Center of Oncology: important experience for future research. Effektivnaya farmakoterapiya = Effective Pharmacotherapy, 2020, Vol. 16, no. 18, pp. 20-29. (In Russ.)
4. Arya S., Wiatrek-Moumoulidis D., Synowsky S.A., Shirran S.L., Botting C.H., Powis S.J., Stewart A.J. Quantitative proteomic changes in LPS-activated monocyte-derived dendritic cells: A SWATH-MS study. Sci. Rep., 2019, Vol. 9, no. 1, 4343. doi: 10.1038/s41598-019-40773-6.
5. Bellanger A.-P., Pallandre J.-R., Borg C., Loeffert S., Gbaguidi-Haore H., Millon L. Human monocyte-derived dendritic cells exposed to microorganisms involved in hypersensitivity pneumonitis induce a Th1-polarized immune response. Clin. Vaccine Immunol., 2013, Vol. 20, no. 8, pp. 1133-1142.